Form 4 for WGS GeneDx Holdings Corp.
Accepted 2025-10-01 00:00:00 ET · period of report 2025-09-30 · accession 0001944119-25-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-01 | 2025-09-30 | WGS | Feeley Kevin | CFO | S - Sale+OE | $108.38 | -6,609 | 3,392 | -66% | -$716.3K |
| D | 2025-10-01 | 2025-09-30 | WGS | Feeley Kevin | CFO | M - OptEx | $32.67 | +1,246 | 10.0K | +14% | +$40.7K |
| D | 2025-10-01 | 2025-09-30 | WGS | Feeley Kevin | CFO | M - OptEx | $0.00 | -1,246 | 4,982 | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-09-30 | S | D | 421 | $110.05 | 3,982 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.3225 to $110.25, inclusive. |
| 2 | Common | Class A Common Stock | 2025-09-30 | S | D | 344 | $105.24 | 9,657 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7. |
| 3 | Common | Class A Common Stock | 2025-09-30 | S | D | 2,715 | $107.68 | 6,555 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.22 to $108.20, inclusive. |
| 4 | Common | Class A Common Stock | 2025-09-30 | S | D | 2,152 | $108.67 | 4,403 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.23 to $109.1754, inclusive. |
| 5 | Common | Class A Common Stock | 2025-09-30 | S | D | 387 | $106.86 | 9,270 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.1354 to $107.01, inclusive. |
| 6 | Common | Class A Common Stock | 2025-09-30 | S | D | 520 | $111.93 | 3,462 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive. |
| 7 | Common | Class A Common Stock | 2025-09-30 | S | D | 70 | $113.68 | 3,392 | D | — | — | (F8) Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 3,392 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 124,633 shares of Class A common stock and options to purchase up to an aggregate of 25,906 shares of Class A common stock, which RSUs and options vest according to their respective terms. |
| 8 | Common | Class A Common Stock | 2025-09-30 | M | A | 1,246 | $32.67 | 10,001 | D | — | — | |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2025-09-30 | M | D | 1,246 | $0.00 | 4,982 | D | $32.67 · — to 2032-08-31 | 1,246 Class A Common Stock | (F9) The award vested or vests as to 6.25% of the total award quarterly over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |